Author reply: To PMID 23972322

Ophthalmology. 2014 Aug;121(8):e39. doi: 10.1016/j.ophtha.2014.02.029. Epub 2014 May 2.

Authors

Carl C Awh¹, Anne Marie Lane², Steven Hawken³, Brent Zanke⁴, Ivana K Kim²

Affiliations

¹ Tennessee Retina, PC, Nashville, Tennessee.
² Retina Service, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts.
³ Ottawa Hospital Research Institute Clinical Epidemiology Program, Ottawa, Canada.
⁴ The Ottawa Hospital Research Institute and the Division of Hematology, University of Ottawa Department of Medicine, Ottawa, Canada; The Arctic Group of Companies, Toronto, Canada.

PMID: 24793507
DOI: 10.1016/j.ophtha.2014.02.029

No abstract available

Publication types

Letter
Comment

MeSH terms

Antioxidants / therapeutic use*
Female
Humans
Macular Degeneration / drug therapy*
Macular Degeneration / genetics*
Male
Polymorphism, Single Nucleotide*
Proteins / genetics*
Zinc Compounds / therapeutic use*

Substances

Antioxidants
Proteins
Zinc Compounds